4//SEC Filing
Donnelly Richard G 4
Accession 0001079973-06-000447
CIK 0001167419other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 5:15 PM ET
Size
10.9 KB
Accession
0001079973-06-000447
Insider Transaction Report
Form 4
Donnelly Richard G
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2006-07-13$1.45/sh+10,000$14,500→ 221,537 total
Holdings
- 28,571
Warrants (Right to Buy)
Exercise: $1.35From: 2005-05-06Exp: 2010-05-06→ Common Stock (28,571 underlying) - 100,000
Options (Right to Buy)
Exercise: $0.96From: 2006-07-01Exp: 2015-12-23→ Common Stock (100,000 underlying) - 500,000
Options (Right to Buy)
Exercise: $0.60From: 2005-02-01Exp: 2015-02-01→ Common Stock (500,000 underlying)
Footnotes (3)
- [F1]Options vest over three years, at the rate of 33.3% at the end of year one, 66.7% at the end of year two, and 100% at the end of year three.
- [F2]Units purchased at a unit price of $0.875, with each unit consisting of one warrant and one share of common stock.
- [F3]Pursuant to Board minutes dated December 23, 2005, the Company's Board of Directors granted Mr. Donnelly stock options to purchase 100,000 shares of the Company's common stock at $0.96 per share. The stock options vest on July 1, 2006, assuming that a cumulative minimum of $500,000 of sales of the new equine LH product is achieved by June 30, 2006. If such sales threshold is not achieved by June 30, 2006, the options shall lapse and expire. This stock option grant is exempt from Section 16(b) pursuant to Rule 16b-3d.
Documents
Issuer
AspenBio Pharma, Inc.
CIK 0001167419
Entity typeother
Related Parties
1- filerCIK 0001316244
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 5:15 PM ET
- Size
- 10.9 KB